Endocrine Surgery Division, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Clin Endocrinol (Oxf). 2024 Jan;100(1):96-101. doi: 10.1111/cen.14993. Epub 2023 Nov 27.
Cervical lymph nodes (LNs) in the central (level VI) and lateral (levels II-V) compartments of the neck are the most common sites of locoregional metastases associated with thyroid cancer. Prophylactic nodal dissections are uncommon in modern thyroid surgery and are not routinely performed due to concern for increased morbidity and do not offer improved survival. Therefore, a selective approach for LN dissections is increasingly important. Preoperatively, this is most frequently assessed with cervical ultrasound (US). Contrast-enhanced computed tomography (CT) of the neck can also be used for preoperative assessment. Both US and CT imaging can be used to characterise LNs in levels II-VI and their risk of malignancy based on size, morphology, and growth. US-guided fine-needle aspiration of equivocal LN with thyroglobulin (Tg) washout can also determine if a LN harbours malignancy. For postoperative surveillance after total thyroidectomy, both US and CT continue to play an important role at 6-12 months intervals. These patients may also benefit from additional biochemical data such as Tg levels in addition to LN and thyroid bed imaging. Thyroid uptake scans may also play a role in LN surveillance postoperatively for well-differentiated thyroid carcinoma in certain clinical contexts. Less commonly, positron emitted tomography may play a role, but is typically reserved for patients with aggressive or radioactive iodine refractory disease.
颈部中央(VI 水平)和侧方(II-V 水平)区的颈部淋巴结(LNs)是与甲状腺癌相关的局部区域转移的最常见部位。预防性淋巴结清扫术在现代甲状腺手术中并不常见,也不常规进行,因为担心增加发病率,且不会提高生存率。因此,LN 清扫术的选择性方法越来越重要。术前,这通常通过颈部超声(US)进行评估。颈部增强 CT(CT)也可用于术前评估。US 和 CT 成像都可用于评估 II-VI 水平的 LNs 及其恶性风险,包括大小、形态和生长。对于具有可疑 Tg 洗脱的 US 引导下细针抽吸的 LNs,也可以确定 LNs 是否存在恶性肿瘤。对于全甲状腺切除术后的随访,US 和 CT 均在 6-12 个月的间隔继续发挥重要作用。这些患者还可能受益于除了 LN 和甲状腺床成像之外的其他生化数据,如 Tg 水平。甲状腺摄取扫描在某些临床情况下也可能在分化型甲状腺癌的术后 LN 监测中发挥作用。不太常见的是,正电子发射断层扫描可能发挥作用,但通常保留给具有侵袭性或放射性碘难治性疾病的患者。